<DOC>
	<DOCNO>NCT00814138</DOCNO>
	<brief_summary>Myasthenia gravis rare neuromuscular disorder characterize weakness fatigability ocular , bulbar , extremity musculature . The specific aim study determine oral methotrexate effective therapy myasthenia gravis ( MG ) patient prednisone dependent . Patients randomize receive either methotrexate placebo enter onto trial symptom sign disease prednisone therapy . The hypothesis add methotrexate therapy patient improve MG manifestation prednisone dose reduce clinical measure MG severity improve . Funding Source - FDA OOPD</brief_summary>
	<brief_title>Efficacy Methotrexate Myasthenia Gravis</brief_title>
	<detailed_description />
	<mesh_term>Muscle Weakness</mesh_term>
	<mesh_term>Myasthenia Gravis</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Patients must MGFA MG grade 2 , 3 , 4 generalize myasthenia gravis , accord MGFA classification system Elevated acetylcholine receptor antibody ( AChRAb ) titer . Patient 's sign symptom well explain another disease process . Prednisone dose least 10 mg/day ( equivalent alternate day ) subject must stable dose prednisone 30 day prior screen visit . A history chronic degenerative , psychiatric , neurologic disorder MG produce weakness fatigue . Other major chronic debilitating illness within six month prior study entry . Female patient premenopausal : ( ) pregnant basis serum pregnancy test , ( b ) breastfeeding , ( c ) use effective method double barrier ( 1 hormonal plus 1 barrier method 2 simultaneous barrier method ) birth control ( birth control pill , male condom , female condom , intrauterine device , Norplant , tubal ligation , sterilization procedure ) . Altered level consciousness , dementia , abnormal mental status . Evidence thymoma chest CT MRI . Such finding could require immediate thymectomy would preclude entry study . Thymectomy previous three month . Patients medicate azathioprine , cyclosporine , cyclophosphamide , mycophenolate mofetil , IVIg , immunosuppressive drug within last 60 day . Chest Xray evidence tumor , infection , interstitial lung disease . Clinical history chronic recurrent infection . Daily use nonsteroidal antiinflammatory drug ( NSAIDs ) . History renal hepatic insufficiency liver enzymes great upper limit normal . History bone marrow hypoplasia , leucopenia , thrombocytopenia , significant anemia , clinical laboratory evidence immunodeficiency syndrome . Forced Vital Capacity ( FVC ) &lt; 50 % predict . MG Grade 1 ( ocular ) 5 ( crisis , require ventilator ) . Prior use methotrexate condition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>myasthenia gravis</keyword>
</DOC>